Favorable Clinician Acceptability of Telehealth as Part of the Cystic Fibrosis Care Model during the COVID-19 Pandemic
Ann Am Thorac Soc
.
2021 Sep;18(9):1588-1592.
doi: 10.1513/AnnalsATS.202012-1484RL.
Authors
Ryan C Perkins
1
2
,
Jaclyn Davis
1
,
Andrew NeSmith
3
,
Julianna Bailey
3
,
Michael R Powers
4
,
Nauman Chaudary
5
,
Christopher Siracusa
6
7
,
Ahmet Uluer
1
2
,
George M Solomon
3
,
Gregory S Sawicki
1
Affiliations
1
Boston Children's Hospital, Boston, Massachusetts, and.
2
Brigham and Women's Hospital, Boston, Massachusetts.
3
University of Alabama at Birmingham, Birmingham, Alabama.
4
Oregon Health & Science University Doernbecher Children's Hospital Portland, Oregon.
5
Virginia Commonwealth University, Richmond, Virginia.
6
Cincinnati Children's Hospital, Cincinnati, Ohio, and.
7
University of Cincinnati College of Medicine, Cincinnati, Ohio.
PMID:
33636092
PMCID:
PMC8489866
DOI:
10.1513/AnnalsATS.202012-1484RL
No abstract available
Publication types
Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
MeSH terms
COVID-19*
Cystic Fibrosis* / therapy
Humans
Pandemics
SARS-CoV-2
Telemedicine*
Grants and funding
K08 HL138153/HL/NHLBI NIH HHS/United States
P30 DK072482/DK/NIDDK NIH HHS/United States